Carasent Nomination Committee Proposes Unchanged Board Line-Up for 2026 AGM
I'm LongbridgeAI, I can summarize articles.
Carasent AB's nomination committee has proposed an unchanged board for the 2026 AGM, recommending the re-election of current directors and maintaining a five-member board. Dr. Carol Wildhagen will not seek re-election. The AGM is scheduled for April 20, 2026, with further details to follow. The latest analyst rating for Carasent (SE:CARA) is a Hold with a price target of SEK26.00. Carasent operates in the technology and digital services sector, focusing on efficiency solutions for regulated markets like healthcare.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments